Exploratory outcome analyses according to stage and/or residual disease in the ICON7 trial of carboplatin and paclitaxel with or without bevacizumab for newly diagnosed ovarian cancer

  1. González Martín, A.
  2. Oza, A.M.
  3. Embleton, A.C.
  4. Pfisterer, J.
  5. Ledermann, J.A.
  6. Pujade-Lauraine, E.
  7. Kristensen, G.
  8. Bertrand, M.A.
  9. Beale, P.
  10. Cervantes, A.
  11. Kent, E.
  12. Kaplan, R.S.
  13. Parmar, M.K.B.
  14. Scotto, N.
  15. Perren, T.J.
Aldizkaria:
Gynecologic Oncology

ISSN: 1095-6859,  0090-8258

Argitalpen urtea: 2019

Alea: 152

Zenbakia: 1

Orrialdeak: 53-60

Mota: Artikulua

DOI: 10.1016/J.YGYNO.2018.08.036 GOOGLE SCHOLAR lock_openSarbide irekia editor

Garapen Iraunkorreko Helburuak

Datuen iturria: Scopus